<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Unipolar depression: Neurobiology
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Unipolar depression: Neurobiology
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Unipolar depression: Neurobiology
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Ranga Krishnan, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Peter P Roy-Byrne, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David Solomon, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Aug 31, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H192888873">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Unipolar depression is a major public health problem associated with increased functional disability and mortality. The illness likely represents a group of heterogeneous disorders that are phenotypically similar [
         <a href="#rid1">
          1
         </a>
         ]. Efforts to understand the neurobiology of depression, as well as its pathogenesis, are intended to discern these different diseases or subtypes.
        </p>
        <p>
         This topic reviews the neurobiology of unipolar depression. The pathogenesis, clinical features, assessment, diagnosis, and treatment of unipolar depression are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/118668.html" rel="external">
          "Unipolar depression: Pathogenesis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/91774.html" rel="external">
          "Unipolar depression in adults: Clinical features"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1721.html" rel="external">
          "Unipolar depression in adults: Assessment and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1725.html" rel="external">
          "Unipolar major depression in adults: Choosing initial treatment"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/14685.html" rel="external">
          "Unipolar depression in adults: Choosing treatment for resistant depression"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H457464432">
         <span class="h1">
          DEFINITIONS OF DEPRESSION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The term "depression" can be used in multiple ways, which can be confusing; depression may refer to a [
         <a href="#rid2">
          2,3
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mood state, as indicated by feelings of sadness, despair, anxiety, emptiness, discouragement, or hopelessness; having no feelings; or appearing tearful. Depressed (dysphoric) mood may be normal or a symptom of a psychopathological syndrome or a general medical disorder.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Syndrome, which is a constellation of symptoms and signs that may include depressed mood. Depressive syndromes that are typically encountered include major depression, minor depression, or dysthymia (persistent depressive disorder).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mental disorder that identifies a distinct clinical condition. As an example, the syndrome of major depression can occur in several disorders, such as unipolar major depression (also called "major depressive disorder"), bipolar disorder, schizophrenia, substance/medication-induced depressive disorder, and depressive disorder due to another (general) medical condition.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3835229369">
         <span class="h1">
          NEUROBIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple lines of evidence demonstrate that unipolar depression is associated with altered brain structure and function. However, studies of the neurobiology of depression often use a cross-sectional design, making it unclear whether observed abnormalities represent etiologic causes, sequelae, both, or neither (the depressive syndrome and observed abnormalities may simply coincide with each other) [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2440791929">
         <span class="h2">
          Hypothalamic-pituitary-adrenal axis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cortisol responses to stress are greater in patients with acute unipolar major depression, as well as remitted patients, compared with healthy controls [
         <a href="#rid5">
          5
         </a>
         ]. It is thought that in many depressed patients, overproduction of corticotropin-releasing hormone causes excess activity of the hypothalamic-pituitary-adrenal cortex axis [
         <a href="#rid6">
          6,7
         </a>
         ]. Prolonged or excessive secretion of glucocorticoids may lead to suppression of neurogenesis and hippocampal atrophy  (
         <a class="graphic graphic_figure graphicRef78677" href="/z/d/graphic/78677.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid8">
          8-10
         </a>
         ].
        </p>
        <p>
         The hypercortisolemia observed in depressed patients was the basis for studies that evaluated the
         <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">
          dexamethasone
         </a>
         suppression test as a tool to diagnose major depression [
         <a href="#rid11">
          11
         </a>
         ]. However, the test has poor sensitivity and fair specificity for this purpose. A meta-analysis found that baseline test results prior to treatment had no prognostic value, but that posttreatment nonsuppression of cortisol in patients was significantly associated with poor outcome [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1778672929">
         <span class="h2">
          Neural networks
         </span>
         <span class="headingEndMark">
          —
         </span>
         A neural network (circuit) consists of interacting brain regions or systems whose activity is highly correlated and distinct from other networks. The neural network model of depression is based upon structural and functional imaging studies and postmortem brain studies [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
         One neural network includes regions of the brain involved in processing emotions (bidirectional projections from the orbital and medial prefrontal cortex and anterior cingulate, to the amygdala and nucleus accumbens), serotonergic projections that modulate this circuit, and the dorsolateral prefrontal cortex (which is critical in the cognitive regulation of emotion) [
         <a href="#rid13">
          13-16
         </a>
         ]. The network is thought to influence autonomic, behavioral, and endocrine aspects of emotion and is impaired during depressive episodes. Exposure to stressors increases activity of serotonergic neurons, which are located in the brainstem (dorsal raphe nucleus) and regulate the prefrontal cortex, amygdala, and other parts of the circuit. In addition, glutamatergic projections from the prefrontal cortex synapse onto GABAergic neurons in the brainstem, which in turn inhibit serotonergic neurons. (See
         <a class="local">
          'Neurotransmitters'
         </a>
         below.)
        </p>
        <p>
         One hypothesis regarding the mechanism of action for antidepressants is that they gradually induce plasticity in neuronal cortical networks, which facilitates recovery of malfunctioning circuits with rehabilitation and psychotherapy [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3734570650">
         <span class="h3">
          Connectivity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple magnetic resonance imaging (MRI) studies indicate that unipolar major depression is associated with dysfunctional connectivity (communication) within different networks:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis of 25 studies assessed resting-state functional connectivity in 556 patients and 518 healthy controls; approximately 25 percent of the patients were receiving pharmacotherapy at the time of imaging [
         <a href="#rid16">
          16
         </a>
         ]. Major depression was associated with:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hyperconnectivity within the default mode network, which may lead to self-referential thoughts
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypoconnectivity within the frontoparietal network, which may lead to rumination and depressive biases towards internal thoughts
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Abnormal connectivity between different networks
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A subsequent study enrolled female youth who had no lifetime history of psychopathology, but were at high risk for depression due to their family history [
         <a href="#rid18">
          18
         </a>
         ]. During prospective follow-up lasting approximately six years, 20 subjects developed unipolar major depression, recovered, and then completed resting-state functional MRI scans; another 20 subjects remained depression-free and were also scanned. The results suggested that youth who developed depression had less connectivity in neural networks associated with emotion regulation. Compared with the depression-free group, adolescents who suffered depression manifested less connectivity between the amygdala and orbitofrontal cortex and between the dorsolateral prefrontal cortex and frontotemporal regions.
        </p>
        <p>
        </p>
        <p>
         One retrospective study used functional MRI to define four separate subtypes ("biotypes") of unipolar major depression, based upon distinct patterns of abnormal resting-state connectivity in frontostriatal and limbic networks [
         <a href="#rid19">
          19
         </a>
         ]. Each subtype was associated with a different symptom profile; in addition, response to repetitive transcranial magnetic stimulation differed among the subtypes, ranging from a low of 23 percent in one subtype to a high of 83 percent in another subtype.
        </p>
        <p>
         One study of patients with unipolar major depression assessed resting-state connectivity between the subcallosal cingulate cortex and other brain regions, and then randomly assigned the patients to pharmacotherapy or psychotherapy [
         <a href="#rid20">
          20
         </a>
         ]. The pattern of connectivity associated with response to one intervention differed from the pattern of connectivity in patients who remitted with the other intervention.
        </p>
        <p class="headingAnchor" id="H3839551844">
         <span class="h2">
          Anatomic abnormalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Central nervous system anatomic abnormalities in major depression are generally modest, and neuroimaging studies thus rely upon quantitative assessment (eg, voxel-based morphometry) of gray and white matter changes, rather than visual evaluation [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1148941300">
         <span class="h3">
          Gray matter volume
         </span>
         <span class="headingEndMark">
          —
         </span>
         The volume of central nervous system gray matter structures is often decreased in unipolar major depression as well as other mental illnesses [
         <a href="#rid22">
          22-25
         </a>
         ]. As an example, a meta-analysis of 193 MRI studies compared the volume of gray matter structures in psychiatric patients (n &gt;7000 patients with unipolar major depression, bipolar disorder, schizophrenia, obsessive-compulsive disorder, substance use disorders, or anxiety disorders) with healthy controls (n &gt;8000) [
         <a href="#rid26">
          26
         </a>
         ]. Gray matter volumes of several brain structures (eg, hippocampus, insula, and anterior cingulate cortex) were smaller in patients than controls. In addition, gray matter volumes were generally comparable across diagnoses, except for a few effects distinguishing depression (and schizophrenia) from other disorders.
        </p>
        <p>
         Structural neuroimaging in patients with longstanding or untreated depression show [
         <a href="#rid21">
          21,27-29
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increased ventricular-brain ratio
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Smaller frontal lobe volumes
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Smaller hippocampal volume
        </p>
        <p>
        </p>
        <p>
         As an example, a meta-analysis of 64 MRI studies showed a number of brain areas were smaller in patients with unipolar major depression (n = 2418), compared with healthy controls (n = 1974) [
         <a href="#rid30">
          30
         </a>
         ]. The largest effect was in the anterior cingulate cortex. Other areas in the frontal lobe that showed reduced volumes in patients were the orbitofrontal cortex and subgenual prefrontal cortex. In addition, smaller volumes were found in the hippocampus, putamen, and caudate nucleus. Subsequent studies also found that major depression was associated with a smaller volume of the anterior cingulate cortex and orbitofrontal cortex (and the temporal lobes and insula) [
         <a href="#rid24">
          24
         </a>
         ], as well as the hippocampus [
         <a href="#rid23">
          23
         </a>
         ] and putamen [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
         A subsequent meta-analysis restricted itself to 11 studies of 400 medication-free patients with unipolar major depression and 424 healthy controls; the patients manifested smaller gray matter volume in the frontal gyrus, parahippocampal gyrus, and the hippocampus [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
         There is evidence that reduced hippocampal volumes precede the onset of depression in some patients. Volumetric MRI of the hippocampus was conducted in 29 adolescents with major depression, 22 healthy adolescents who had no personal history of a psychiatric illness but were at high risk for developing depression by virtue of at least one biological parent with a history of major depression, and 32 controls with no personal or family psychiatric history [
         <a href="#rid32">
          32
         </a>
         ]. Compared with controls:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The left hippocampus was smaller in the depressed group by 3.1 percent and the right by 3.0 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The left hippocampus was smaller in the high-risk group by 4.2 percent and the right by 4.9 percent.
        </p>
        <p>
        </p>
        <p>
         Further evidence that reduced hippocampal volume precedes depression was found in a study of 23 daughters of mothers with recurrent episodes of depression during the daughter's lifetime (high risk) and 32 age-matched daughters of mothers with no psychiatric history (low risk) [
         <a href="#rid33">
          33
         </a>
         ]. The daughters were all 9 to 15 years old, and none had any history of psychopathology. MRI found smaller hippocampal volumes in high-risk girls compared with low-risk girls. In particular, the left hippocampus was reduced by 3.5 percent. In addition, a meta-analysis of 193 neuroimaging studies (n &gt;15,000 psychiatric patients) found that gray matter volume in the hippocampus was less in patients with unipolar major depression than patients with other disorders (bipolar disorder, obsessive-compulsive disorder, and anxiety disorders) [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
         Neuroimaging also suggests that age related neurodevelopment (eg, synaptic elimination, dendritic pruning, and myelination) in major depression may be abnormally accelerated:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An MRI study estimated the difference between neuroanatomic age and chronologic age in the brains of depressed patients (n = 104); neuroanatomic age was based upon images from healthy controls (n = 800) [
         <a href="#rid34">
          34
         </a>
         ]. In depressed patients, neuroanatomic age was greater than chronologic age (four years), and the gap seemed to be greater among patients with early onset disease compared to patients with late onset.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Another MRI study, which included 116 patients with unipolar major depression and 116 healthy controls, found that age-related reduction of the putamen was twice as large in the depressed group [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Information about the association between depression and increased pruning of cortical gray matter is discussed elsewhere in this topic. (See
         <a class="local">
          'Pruning'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4284748050">
         <span class="h4">
          Course of illness
         </span>
         <span class="headingEndMark">
          —
         </span>
         Remission of depression may be associated with an increase in whole brain volume. A prospective observational study of patients who received pharmacotherapy for treatment resistant depression found that patients who remitted for six months (n = 12) manifested an increase in whole brain volume, including gray matter volume [
         <a href="#rid35">
          35
         </a>
         ]. By contrast, patients who failed to remit for 12 months manifested decreased white matter volume.
        </p>
        <p>
         Recurrence of depression may be associated with loss of gray matter [
         <a href="#rid36">
          36
         </a>
         ]. A retrospective study included patients hospitalized for unipolar major depression and assessed with structural MRIs at baseline and approximately two years later [
         <a href="#rid37">
          37
         </a>
         ]. Among patients who recovered from the index episode and then suffered at least one recurrent episode (n = 37), cortical gray matter volumes decreased in the dorsolateral prefrontal cortex and insula. Among patients without a recurrence, gray matter volumes in these areas remained stable. Use of psychotropic medication and depression severity were not associated with gray matter volumes.
        </p>
        <p class="headingAnchor" id="H2840025483">
         <span class="h3">
          White matter integrity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Unipolar depression is associated with microstructural deficits in central nervous system white matter tracts [
         <a href="#rid21">
          21
         </a>
         ]. White matter deficits may underlie dysfunction of fronto/corticolimbic neural circuits implicated in the pathogenesis of depression, including circuits involved in emotion regulation. (See
         <a class="local">
          'Neural networks'
         </a>
         above.)
        </p>
        <p>
         Diffusion tensor MRI studies in patients with unipolar major depression have identified deficits in white matter tracts traversing multiple areas, including the corpus callosum and superior longitudinal fasciculus [
         <a href="#rid38">
          38
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis of 23 studies assessed white matter integrity in 736 patients and 668 controls; 29 percent of the patients were receiving pharmacotherapy at the time of imaging [
         <a href="#rid39">
          39
         </a>
         ]. Major depression was associated with white matter abnormalities in the corpus callosum.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Another meta-analysis included 15 studies with 434 patients and 429 controls, and avoided the confounding effect of medications by including only those studies with medication-free patients [
         <a href="#rid40">
          40
         </a>
         ]. Major depression was characterized by white matter deficits in the corpus callosum, cerebellum, superior longitudinal fasciculus, and the arcuate network.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A subsequent study enrolled 577 patients and 1867 controls; white matter integrity was disrupted in the superior longitudinal fasciculus, superior thalamic radiation, and forceps major [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Disruption of white matter tracts is also seen in pediatric depression. Two diffusion tensor MRI studies of unmedicated adolescents with depression (n = 52 and 25) and healthy controls (n = 42 and 21) both found microstructure abnormalities in the uncinate fasciculus, which connects the amygdala and hippocampus with the prefrontal cortex [
         <a href="#rid42">
          42,43
         </a>
         ].
        </p>
        <p>
         Another study found evidence that patients with current melancholic major depression were distinguished from patients with current nonmelancholic major depression and from controls with no history of depression by white matter abnormalities in the right anterior limb of the internal capsule, which connects the thalamus to the cingulate and frontal cortices [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2148462357">
         <span class="h2">
          Cellular alterations
         </span>
         <span class="headingEndMark">
          —
         </span>
         The number, density, and size of neurons and glial cells in patients with major depression are abnormal.
        </p>
        <p>
         Postmortem studies found that the density of certain gamma-aminobutyric acid (GABA) neurons in the occipital cortex was reduced by 28 percent in patients with major depression compared with psychiatrically healthy controls, and by 50 percent in the prefrontal cortex [
         <a href="#rid45">
          45,46
         </a>
         ]. These changes are consistent with findings that levels of GABA are altered in depression. (See
         <a class="local">
          'Neurotransmitters'
         </a>
         below.)
        </p>
        <p>
         The size of neurons in the prefrontal cortex was decreased by 18 to 20 percent in postmortem brain specimens from patients with major depression compared with healthy controls and by 23 percent in the anterior cingulate cortex [
         <a href="#rid46">
          46-48
         </a>
         ].
        </p>
        <p>
         A review found that the density and number of glial cells was reduced in major depression [
         <a href="#rid49">
          49
         </a>
         ]. This included decreases in the prefrontal cortex, especially the orbital prefrontal cortex, dorsolateral prefrontal cortex, amygdala, and anterior cingulate cortex. In addition, impaired glial cell functions (glutamate metabolism, production of neurotrophic factors, and myelination) probably contribute to the pathophysiology of depression.
        </p>
        <p class="headingAnchor" id="H2092507957">
         <span class="h3">
          Pruning
         </span>
         <span class="headingEndMark">
          —
         </span>
         Depression may be associated with increased pruning of cortical gray matter. Selective elimination of gray matter normally occurs during adolescence, resulting in volume loss and thinning. One study using prospective and retrospective data included children (n = 193) who underwent MRI multiple times; the children were three to six years of age at study enrollment and were followed for up to 11 years [
         <a href="#rid50">
          50
         </a>
         ]. After controlling for potential confounding factors (eg, age, sex, ratio of income to needs, use of psychotropic medications, and psychiatric comorbidity), the analyses found that gray matter volume loss and thinning were greater in children with unipolar major depression than nondepressed children. Cortical gray matter volume decreased more rapidly in children with more depressive symptoms, such that reduction in volume was nearly two times faster in children with five symptoms, compared with children with no depressive symptoms. By contrast, family history of depression and traumatic experiences were not associated with alterations in the trajectory of gray matter maturation. The investigators speculated that the cortical changes associated with childhood depression may be related to experience-dependent neuroplasticity, rather than other genetic or psychosocial processes.
        </p>
        <p class="headingAnchor" id="H849691665">
         <span class="h2">
          Vascular function
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple studies suggest that late-life depression is associated with peripheral and cerebral vascular dysfunction:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A series of meta-analyses pooled data from 48 studies with more than 43,000 participants (mean age 66 years), including more than 9000 individuals with depression [
         <a href="#rid51">
          51
         </a>
         ]. Most of the studies were cross-sectional. The investigators found that:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Higher levels of the plasma endothelial biomarker soluble intercellular adhesion molecule-1 occurred more often in depressed individuals than nondepressed individuals (odds ratio 1.6, 95% CI 1.3-2.0). Increased levels of the marker indicate dysfunction.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Increased severity of white matter hyperintensities, indicating cerebral small vessel disease, occurred more often in individuals with depression than those without depression (odds ratio 1.3, 95% CI 1.2-1.4).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pooled results from prospective studies of individuals without depression at baseline, who were followed for an average of four years, found that new onset of depressive syndromes was more likely to occur in individuals with more severe white matter hyperintensities, compared to individuals with less severe lesions (odds ratio 1.2, 95% CI 1.1-1.3).
        </p>
        <p>
        </p>
        <p>
         In addition, depression during late life, especially depression with first onset in late life (eg, age 60 years or greater), is accompanied by more diffuse cerebrovascular dysfunction than early onset depression. In a meta-analysis of five cross-sectional MRI studies (n = 220 patients with late-life depression), periventricular white matter abnormalities were detected five times more often in patients with late-onset compared with early-onset depression (odds ratio 5, 95% CI 2-9); in addition, deep white matter hyperintensities (nine studies, 542 patients) were detected four times more often in patients with late-onset depression (odds ratio 4, 95% CI 3-7) [
         <a href="#rid52">
          52
         </a>
         ]. This suggests that the structural abnormalities represented by white matter hyperintensities may be part of the etiology of late-onset depression. The investigators reasoned that if the reverse were true (ie, if depression or its treatment caused white matter hyperintensities), one would expect to find these lesions more often in patients with early-onset depression because of their longer duration of illness. Nevertheless, other explanations may account for the study results, such as an underlying pathologic process that predisposes older individuals to concurrently develop both depression and white matter lesions.
        </p>
        <p>
         Additional information about cerebrovascular disease and depression is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1093.html" rel="external">
          "Complications of stroke: An overview", section on 'Depression'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1719.html" rel="external">
          "Diagnosis and management of late-life unipolar depression"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1427300264">
         <span class="h2">
          Brain activity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Functional neuroimaging shows that unipolar major depression is associated with increased or decreased activity in several brain areas, including those that may be involved in emotion regulation and reward processing [
         <a href="#rid21">
          21
         </a>
         ]. In addition, changes in activity occur after treatment. Although metabolic studies have been used to diagnose depression and predict treatment response, functional neuroimaging for these purposes is not standard practice.
        </p>
        <p>
         Imaging studies of brain activity differ in their methods, including whether subjects are performing a cognitive task during data acquisition or resting quietly, as well as the type of neuroimaging that is used. These differences may be related to varying or inconsistent results across studies:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis of 14 functional MRI studies included youth aged 4 to 24 years who were diagnosed with unipolar major depression (n = 246) and healthy controls matched on age (n = 274); the studies examined central nervous system activity during tasks involving affective processing and executive functioning (eg, planning) [
         <a href="#rid53">
          53
         </a>
         ]. The analyses found consistent patterns of abnormal activation in the depressed group, including:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Diminished activation in the cuneus and insula as well as heightened activity in the dorsolateral prefrontal cortex and superior temporal cortex, which may be related to negative affect and anhedonia.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Overactivity in the anterior cingulate cortex and thalamus, which may explain hypervigilance toward emotional stimuli.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A subsequent meta-analysis of eight studies examined regional cerebral blood flow in 198 medication-free patients and 227 healthy controls; both groups rested quietly during neuroimaging, which consisted of single photon emission computed tomography, positron emission tomography, or MRI [
         <a href="#rid54">
          54
         </a>
         ]. Compared with controls, cerebral blood flow in the patients was:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Increased in the caudate nucleus, insula, precuneus, hippocampus, and posterior cingulate cortex
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Decreased in the frontal gyrus and anterior cingulate cortex
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1662505928">
         <span class="h3">
          Reward networks
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple imaging studies have found that major depression is associated with abnormal activity within brain circuits (eg, the ventral tegmental area and nucleus accumbens network) that are thought to be involved in reward processing [
         <a href="#rid55">
          55
         </a>
         ]. As an example, functional MRIs assessed brain activity in 30 patients with unipolar major depression and in 31 healthy controls during a task related to monetary gain (reward processing) [
         <a href="#rid56">
          56
         </a>
         ]. Compared with controls, patients demonstrated weaker responses to monetary gains in the nucleus accumbens and caudate.
        </p>
        <p>
         In addition, prospective studies in healthy individuals indicate that decreased striatal activity at baseline predicts subsequent depressive syndromes [
         <a href="#rid57">
          57,58
         </a>
         ]. A study performed functional MRIs in healthy subjects (n &gt;1000) during a task involving monetary incentives and assessed the subjects two years later for depression [
         <a href="#rid59">
          59
         </a>
         ]. Decreased activation of the ventral striatum at baseline was associated with an increased risk of depressive syndromes at follow-up. In addition, a dose-response effect was observed, such that baseline striatal activation was lowest in subjects who developed probable major depression, highest in subjects who remained healthy, and intermediary in those who developed minor depression.
        </p>
        <p class="headingAnchor" id="H1590342238">
         <span class="h3">
          Association with treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Regional cerebral metabolic activity patterns may change with treatment of depression. One observational study using both prospective and retrospective data found that after depressed patients were successfully treated, metabolic changes occurred in different brain regions, depending upon whether patients received pharmacotherapy or psychotherapy [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p>
         In addition, regional cerebral metabolic activity may be associated with treatment outcomes. A prospective observational study enrolled 61 patients with unipolar major depression who had not been treated with antidepressants and obtained arterial spin-labelling MRIs before commencing antidepressants [
         <a href="#rid61">
          61
         </a>
         ]. In patients who responded poorly to at least two adequate antidepressant trials, baseline cerebral perfusion was lower in limbic-striatal areas, compared with patients who responded to treatment.
        </p>
        <p class="headingAnchor" id="H3177448602">
         <span class="h2">
          Sleep and circadian rhythms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Changes in sleep architecture during depression include decreased [
         <a href="#rid62">
          62,63
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rapid eye movement latency
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Slow-wave sleep
        </p>
        <p>
        </p>
        <p>
         Depression is also associated with alterations in central circadian rhythms that are related to diurnal variation in symptoms. Blunted circadian rhythms involve body temperature, blood pressure, pulse, plasma cortisol, norepinephrine, thyroid stimulating hormone, and melatonin [
         <a href="#rid64">
          64
         </a>
         ]. The abnormal rhythms return to normal with antidepressant treatment and probably underlie the therapeutic benefits of circadian rhythm phase-shifting via light therapy or sleep deprivation [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
         Information about circadian rhythms and seasonal affective disorder is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1705.html" rel="external">
          "Seasonal affective disorder: Epidemiology, clinical features, assessment, and diagnosis", section on 'Pathogenesis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H467405662">
         <span class="h2">
          Inflammation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple psychiatric disorders are associated with inflammation, and several studies have established that unipolar major depression is associated with higher mean serum concentrations of peripheral inflammatory markers, including the cytokines tumor necrosis factor and interleukin-6 (IL-6) and the acute phase reactant C-reactive protein (CRP) [
         <a href="#rid66">
          66-71
         </a>
         ]. As an example:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a cross-sectional population study (n = 852 adults) that controlled for potential confounding factors (eg, age, sex, and smoking), serum biomarkers of low-grade inflammation such as CRP and tumor necrosis factor were associated with the presence of major depression and minor depression (odds ratio 1.6, 95% CI 1.2-2.1) [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A prospective observational study measured serum concentrations of IL-6 at age nine years and then assessed the subjects for depression at age 18 years (approximately 4500 subjects). After adjusting for sociodemographic and clinical variables (eg, past mental health problems), subjects in the top third of IL-6 values compared with the bottom third at age nine years were more likely to be depressed at age 18 years (odds ratio 1.6, 95% CI 1.1-2.1) [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Furthermore, markers of inflammation are hypothesized to define a subpopulation of depressed individuals most likely to benefit from anti-inflammatory treatment. This theory is supported by data from a pooled analysis of 15 prospective studies including 56,351 individuals with depressive symptoms demonstrating that systemic inflammation is primarily associated with physical symptoms [
         <a href="#rid72">
          72
         </a>
         ]. Elevated CRP or IL-6 was associated with changes in appetite, feeling as if everything is a great effort, loss of energy, sleep difficulties, and concentration difficulties. In contrast, there was no association between the inflammatory markers and specific emotional symptoms such as fearfulness, hopelessness, feeling “bothered” by things, and feeling as if life has been a failure.
        </p>
        <p>
         However, it is not clear that increased peripheral inflammation reflects increased central nervous system inflammation [
         <a href="#rid73">
          73
         </a>
         ].
        </p>
        <p>
         Inflammation may also be related to treatment resistant depression [
         <a href="#rid73">
          73,74
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A study enrolled unmedicated outpatients with current major depression (n = 98), measured immune markers, and retrospectively assessed the number of prior antidepressant trials during the current episode [
         <a href="#rid75">
          75
         </a>
         ]. A greater number of failed trials was associated with increased serum levels of tumor necrosis factor, IL-6, and soluble tumor necrosis factor receptor 2. In addition, patients with three or more failed trials had higher levels of each marker than patients with zero or one failed trial.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Studies have found that among patients with depression, increased levels of acute phase reactants or cytokines prior to treatment were associated with a decreased response [
         <a href="#rid76">
          76
         </a>
         ]. In addition, serum concentrations of inflammatory markers are elevated in patients with a history of nonresponse to antidepressants, compared with treatment responsive patients.
        </p>
        <p>
        </p>
        <p>
         The hypothesis that inflammation may be associated with depression is supported by positive results from randomized trials of anti-inflammatory agents in depressed patients [
         <a href="#rid77">
          77
         </a>
         ].
        </p>
        <p>
         In addition, randomized trials that evaluated cytokine modulators in patients with chronic inflammatory disorders (eg, psoriasis or rheumatoid arthritis) found that these anti-inflammatory drugs improved comorbid depression [
         <a href="#rid78">
          78
         </a>
         ].
        </p>
        <p>
         Inflammation in major depression may be related to changes in connectivity (communication) between different areas of the brain. Resting-state MRIs in 48 medication-free patients with major depression found that increased serum levels of CRP were associated with decreased connectivity between the [
         <a href="#rid79">
          79
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ventral striatum and the prefrontal cortex, which in turn correlated with increased anhedonia
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dorsal striatum and the prefrontal cortex, which in turn correlated with increased psychomotor slowing
        </p>
        <p>
        </p>
        <p>
         In addition, increased serum levels of other inflammatory cytokines (IL-6, interleukin-1 beta, and interleukin-1 receptor antagonist) were associated with decreased connectivity between the striatum and prefrontal cortex.
        </p>
        <p>
         Additional information about major depression and connectivity is discussed elsewhere in this topic. (See
         <a class="local">
          'Connectivity'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H2534227304">
         <span class="h2">
          Telomere length
         </span>
         <span class="headingEndMark">
          —
         </span>
         Depression is associated with abnormally short telomeres; this association is thought to represent accelerated cellular aging [
         <a href="#rid80">
          80
         </a>
         ]. Telomeres are nucleotide sequences that are found at both ends of chromosomes and are thought to protect the chromosome from damage. The length of telomeres normally decrease over time in a progressive fashion, and this process is viewed as a marker of cellular age.
        </p>
        <p>
         Studies that suggest depression is associated with short telomeres include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis of 11 studies (n &gt;5000 depressed patients and healthy controls) found that telomere length was shorter in the depressed group than the controls, and the difference was moderately large [
         <a href="#rid81">
          81
         </a>
         ]. However, heterogeneity across studies was substantial.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a meta-analysis of 38 studies (n &gt;34,000 depressed patients and controls), telomere length was shorter in the depressed group than the nondepressed group [
         <a href="#rid82">
          82
         </a>
         ]. However, the difference in telomere length between the two groups was small and there was evidence of publication bias.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A subsequent study examined telomere length in patients with depressive and/or anxiety disorders (n &gt;1500) and in healthy controls (n &gt;600); after adjusting for potential confounding factors (eg, age, sex, and chronic diseases), the analyses showed that telomere length was shorter in patients than controls [
         <a href="#rid83">
          83
         </a>
         ]. In addition, patients with the most severe depressive/anxiety symptoms had the shortest telomeres [
         <a href="#rid84">
          84
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Race and ethnicity may mediate the relationship between depression and telomere length. A study of more than 2700 individuals found that telomere length was shorter in White Americans with depression than nondepressed White Americans, whereas in Black Americans or Hispanics, depression was not associated with telomere length [
         <a href="#rid85">
          85
         </a>
         ].
        </p>
        <p>
         Most of the studies examining depression and telomere length have been cross-sectional studies. Although the direction of the association is unclear, it appears that depression is associated with short telomeres, but that short telomeres are not associated with depression:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis of 25 studies (n &gt;21,000 depressed patients and controls) found that telomere length was shorter in the depressed group than the controls [
         <a href="#rid86">
          86
         </a>
         ]. In the five longitudinal studies, there was no relationship between depression and telomere length, whereas in the cross-sectional studies, depression was associated with telomere length.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a subsequent study that measured telomere length at study entry, mean telomere length was shorter in individuals (n = 370) who were previously hospitalized for depression (before study entry), compared to individuals (n &gt;53,000) with no such prior history [
         <a href="#rid87">
          87
         </a>
         ]. Following study entry, individuals with no past history of depression were followed prospectively for an average of eight years; short telomeres at baseline were not associated with an increased risk of depression.
        </p>
        <p>
        </p>
        <p>
         These results are consistent with the hypothesis that depression causes physiologic changes that shorten telomeres [
         <a href="#rid86">
          86
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3170438721">
         <span class="h2">
          Neurotransmitters
         </span>
         <span class="headingEndMark">
          —
         </span>
         Depression involves abnormal functioning of several neurotransmitters, including:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Monoamines (serotonin, norepinephrine, and dopamine)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         GABA
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glutamate
        </p>
        <p>
        </p>
        <p>
         Early theoretical models postulated that depression is due to diminished neurotransmission of monoamines, particularly serotonin and norepinephrine. It now appears that more complex dynamics, including intracellular cascades triggered by the monoamines, are involved in the onset of depression and the response to antidepressant medications [
         <a href="#rid88">
          88
         </a>
         ].
        </p>
        <p>
         The role of the serotonergic system has been repeatedly demonstrated in an experimental model that rapidly depletes tryptophan, the precursor amino acid required for central synthesis of serotonin. Patients in remission from major depression with selective serotonin reuptake inhibitors often exhibit a severe, rapid relapse after acute tryptophan depletion [
         <a href="#rid89">
          89,90
         </a>
         ]. In addition, a meta-analysis of nine observational studies showed that serum concentrations of tryptophan were significantly lower in unmedicated patients with major depression (n = 156) than controls (n = 203), and the clinical difference was large [
         <a href="#rid91">
          91
         </a>
         ].
        </p>
        <p>
         The role of catecholamine system (norepinephrine and dopamine) has also been examined using a depletion paradigm with alpha-methyl-para-tyrosine, which rapidly depletes catecholamines by inhibiting their synthesis. A study found that patients treated with
         <a class="drug drug_general" data-topicid="9329" href="/z/d/drug information/9329.html" rel="external">
          desipramine
         </a>
         , a norepinephrine reuptake inhibitor, suffered a rapid increase in depression rating scale scores after taking alpha-methyl-para-tyrosine but not after taking placebo [
         <a href="#rid92">
          92
         </a>
         ].
        </p>
        <p>
         Decreased dopamine transmission has been associated with depression in genetic, neurochemical, neuroimaging, postmortem, and animal studies [
         <a href="#rid93">
          93
         </a>
         ]. These studies support the hypothesis that some patients have a subtype of depression that is dopamine-sensitive and resistant to treatment with antidepressants that act initially on the serotonin and norepinephrine pathways.
        </p>
        <p>
         Numerous studies implicate changes in GABA and glutamate in the pathophysiology of depression [
         <a href="#rid94">
          94
         </a>
         ]. Magnetic resonance spectroscopy studies in medication-free subjects with major depression observed elevated levels of glutamate and lower levels of GABA in the occipital cortex [
         <a href="#rid95">
          95
         </a>
         ], and found that increased basal ganglia glutamate was associated with increased anhedonia and increased psychomotor slowing [
         <a href="#rid96">
          96
         </a>
         ]. In addition, abnormal reductions in glutamate/glutamine and GABA concentrations were found in the prefrontal cortex of unmedicated depressed patients [
         <a href="#rid97">
          97
         </a>
         ]. These findings suggest that the changes in glutamate and GABA may vary by brain region. A gene expression study in the cingulate and prefrontal cortex of depressed suicides found significant alterations in glutamate recycling (glutamine synthase and GLUL), glutamate receptors (GRIA1, GRIA3, GRIK1, GRM3), and GABA receptors (GABARB3, GABRD, GABARG2) in depressed suicides versus controls [
         <a href="#rid98">
          98
         </a>
         ].
        </p>
        <p>
         Glutamate antagonists may thus be beneficial in treating major depression. (See
         <a class="medical medical_review" href="/z/d/html/119992.html" rel="external">
          "Ketamine and esketamine for treating unipolar depression in adults: Administration, efficacy, and adverse effects"
         </a>
         .)
        </p>
        <p>
         Other neurotransmitters and neuromodulators may play a role in depression. These include endocannabinoids and the CB1 receptor, brain-derived neurotrophic factor (BDNF), acetylcholine, protein p11, and substance P [
         <a href="#rid99">
          99-102
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Blockade of the cannabinoid CB1 receptor by the weight loss and smoking cessation medication rimonabant was associated with onset of depression symptoms to the extent that further drug development was suspended [
         <a href="#rid102">
          102
         </a>
         ]. Circulating endocannabinoid ligands are reduced in patients with depression.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         BDNF appears to be involved in depression by linking stress, neurogenesis, and hippocampal atrophy [
         <a href="#rid103">
          103,104
         </a>
         ]. However, BDNF may be a component of a wide range of psychopathology beyond depression.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2127507084">
         <span class="h2">
          Acetyl-L-carnitine
         </span>
         <span class="headingEndMark">
          —
         </span>
         Serum levels of acetyl-L-carnitine, an endogenously produced molecule, may be decreased in unipolar depression. In one study of patients with acute unipolar major depression (n = 71) and age- and sex-matched healthy controls (n = 45), mean acetyl-L-carnitine levels were lower in patients than controls and the clinical difference was large [
         <a href="#rid105">
          105
         </a>
         ]. In addition, the levels were lower in male patients than male controls, and in female patients than female controls. Other analyses found that higher scores on the depression rating scale and an earlier age of onset were each associated with lower serum concentrations of acetyl-L-carnitine.
        </p>
        <p>
         These results suggest that acetyl-L-carnitine may be a biomarker that can help diagnose unipolar major depression. In addition, it may be possible to treat patients with exogenous acetyl-L-carnitine [
         <a href="#rid106">
          106
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2556950985">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Unipolar depression likely represents a group of heterogeneous disorders that are phenotypically similar. Depression can thus be considered the final common pathway of different disease processes that occur across a biopsychosocial continuum. (See
         <a class="medical medical_review" href="/z/d/html/118668.html" rel="external">
          "Unipolar depression: Pathogenesis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3014797987">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/116503.html" rel="external">
          "Society guideline links: Depressive disorders"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3734252992">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cortisol responses to stress are elevated in patients with acute unipolar major depression, as well as remitted patients. (See
         <a class="local">
          'Hypothalamic-pituitary-adrenal axis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A neural network (circuit) consists of interacting brain regions or systems whose activity is highly correlated and distinct from other networks. Unipolar major depression is associated with dysfunctional connectivity (communication) within different networks. (See
         <a class="local">
          'Neural networks'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Central nervous system anatomic abnormalities in unipolar major depression, which are generally modest, include decreased volume of gray matter structures. As an example, the hippocampus is smaller in depressed patients, and it appears that this reduced volume precedes onset of depression in at least some patients. In addition, depression is associated with microstructural deficits in white matter tracts. (See
         <a class="local">
          'Anatomic abnormalities'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The number, density, and size of neurons and glial cells in patients with major depression are abnormal. (See
         <a class="local">
          'Cellular alterations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Late-life depression is associated with peripheral and cerebral vascular dysfunction. (See
         <a class="local">
          'Vascular function'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Unipolar major depression is associated with altered activity in several brain areas, including those that may be involved in emotion regulation and reward processing. (See
         <a class="local">
          'Brain activity'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Unipolar major depression is also associated with higher mean serum concentrations of peripheral inflammatory markers, including the cytokines tumor necrosis factor and interleukin-6 and the acute phase reactant C-reactive protein. (See
         <a class="local">
          'Inflammation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Depression is associated with abnormally short telomeres; this association is thought to represent accelerated cellular aging. Telomeres are nucleotide sequences that are found at both ends of chromosomes and are thought to protect the chromosome from damage. (See
         <a class="local">
          'Telomere length'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Depression involves abnormal functioning of several neurotransmitters, including serotonin, norepinephrine, dopamine, gamma-aminobutyric acid, and glutamate. (See
         <a class="local">
          'Neurotransmitters'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Unipolar depression likely represents a group of heterogeneous disorders that are phenotypically similar. Depression can thus be considered the final common pathway of different disease processes that occur across a biopsychosocial continuum. (See
         <a class="medical medical_review" href="/z/d/html/118668.html" rel="external">
          "Unipolar depression: Pathogenesis"
         </a>
         .)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Parker G. The benefits of antidepressants: news or fake news? Br J Psychiatry 2018; 213:454.
          </a>
         </li>
         <li class="breakAll">
          American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, 2013.
         </li>
         <li class="breakAll">
          Shahrokh NC, Hales RE, Phillips KA, Yudofsky SC. The Language of Mental health: A Glossary of Psychiatric Terms, American Psychiatric Publishing, Inc, Washington, DC 2011.
         </li>
         <li>
          <a class="nounderline abstract_t">
           aan het Rot M, Mathew SJ, Charney DS. Neurobiological mechanisms in major depressive disorder. CMAJ 2009; 180:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ming Q, Zhong X, Zhang X, et al. State-Independent and Dependent Neural Responses to Psychosocial Stress in Current and Remitted Depression. Am J Psychiatry 2017; 174:971.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vreeburg SA, Hoogendijk WJ, van Pelt J, et al. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry 2009; 66:617.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gillespie CF, Nemeroff CB. Hypercortisolemia and depression. Psychosom Med 2005; 67 Suppl 1:S26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belmaker RH, Agam G. Major depressive disorder. N Engl J Med 2008; 358:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heim C, Nemeroff CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 2001; 49:1023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000; 57:925.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry. Am J Psychiatry 1987; 144:1253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ribeiro SC, Tandon R, Grunhaus L, Greden JF. The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry 1993; 150:1618.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010; 35:192.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cullen KR, Westlund MK, Klimes-Dougan B, et al. Abnormal amygdala resting-state functional connectivity in adolescent depression. JAMA Psychiatry 2014; 71:1138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci 2008; 1124:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaiser RH, Andrews-Hanna JR, Wager TD, Pizzagalli DA. Large-Scale Network Dysfunction in Major Depressive Disorder: A Meta-analysis of Resting-State Functional Connectivity. JAMA Psychiatry 2015; 72:603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Castrén E. Neuronal network plasticity and recovery from depression. JAMA Psychiatry 2013; 70:983.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fischer AS, Camacho MC, Ho TC, et al. Neural Markers of Resilience in Adolescent Females at Familial Risk for Major Depressive Disorder. JAMA Psychiatry 2018; 75:493.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drysdale AT, Grosenick L, Downar J, et al. Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med 2017; 23:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dunlop BW, Rajendra JK, Craighead WE, et al. Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder. Am J Psychiatry 2017; 174:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lui S, Zhou XJ, Sweeney JA, Gong Q. Psychoradiology: The Frontier of Neuroimaging in Psychiatry. Radiology 2016; 281:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belden AC, Barch DM, Oakberg TJ, et al. Anterior insula volume and guilt: neurobehavioral markers of recurrence after early childhood major depressive disorder. JAMA Psychiatry 2015; 72:40.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmaal L, Veltman DJ, van Erp TG, et al. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol Psychiatry 2016; 21:806.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmaal L, Hibar DP, Sämann PG, et al. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Mol Psychiatry 2017; 22:900.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sacchet MD, Camacho MC, Livermore EE, et al. Accelerated aging of the putamen in patients with major depressive disorder. J Psychiatry Neurosci 2017; 42:164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goodkind M, Eickhoff SB, Oathes DJ, et al. Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry 2015; 72:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry 2003; 160:1516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lampe IK, Hulshoff Pol HE, Janssen J, et al. Association of depression duration with reduction of global cerebral gray matter volume in female patients with recurrent major depressive disorder. Am J Psychiatry 2003; 160:2052.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor WD, Macfall JR, Payne ME, et al. Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms. Psychol Med 2007; 37:1763.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ, et al. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp 2009; 30:3719.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhao YJ, Du MY, Huang XQ, et al. Brain grey matter abnormalities in medication-free patients with major depressive disorder: a meta-analysis. Psychol Med 2014; 44:2927.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rao U, Chen LA, Bidesi AS, et al. Hippocampal changes associated with early-life adversity and vulnerability to depression. Biol Psychiatry 2010; 67:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen MC, Hamilton JP, Gotlib IH. Decreased hippocampal volume in healthy girls at risk of depression. Arch Gen Psychiatry 2010; 67:270.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koutsouleris N, Davatzikos C, Borgwardt S, et al. Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders. Schizophr Bull 2014; 40:1140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Phillips JL, Batten LA, Aldosary F, et al. Brain-volume increase with sustained remission in patients with treatment-resistant unipolar depression. J Clin Psychiatry 2012; 73:625.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Phillips ML. A Promising Future Role for Neuroimaging in Tracking and Predicting Relapse in Major Depressive Disorder. JAMA Psychiatry 2018; 75:424.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zaremba D, Dohm K, Redlich R, et al. Association of Brain Cortical Changes With Relapse in Patients With Major Depressive Disorder. JAMA Psychiatry 2018; 75:484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhong X, Shi H, Ming Q, et al. Whole-brain resting-state functional connectivity identified major depressive disorder: A multivariate pattern analysis in two independent samples. J Affect Disord 2017; 218:346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wise T, Radua J, Nortje G, et al. Voxel-Based Meta-Analytical Evidence of Structural Disconnectivity in Major Depression and Bipolar Disorder. Biol Psychiatry 2016; 79:293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jiang J, Zhao YJ, Hu XY, et al. Microstructural brain abnormalities in medication-free patients with major depressive disorder: a systematic review and meta-analysis of diffusion tensor imaging. J Psychiatry Neurosci 2017; 42:150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shen X, Reus LM, Cox SR, et al. Subcortical volume and white matter integrity abnormalities in major depressive disorder: findings from UK Biobank imaging data. Sci Rep 2017; 7:5547.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LeWinn KZ, Connolly CG, Wu J, et al. White matter correlates of adolescent depression: structural evidence for frontolimbic disconnectivity. J Am Acad Child Adolesc Psychiatry 2014; 53:899.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aghajani M, Veer IM, van Lang ND, et al. Altered white-matter architecture in treatment-naive adolescents with clinical depression. Psychol Med 2014; 44:2287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hyett MP, Perry A, Breakspear M, et al. White matter alterations in the internal capsule and psychomotor impairment in melancholic depression. PLoS One 2018; 13:e0195672.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maciag D, Hughes J, O'Dwyer G, et al. Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies. Biol Psychiatry 2010; 67:465.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rajkowska G, O'Dwyer G, Teleki Z, et al. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 2007; 32:471.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cotter D, Mackay D, Chana G, et al. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 2002; 12:386.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cotter D, Mackay D, Landau S, et al. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 2001; 58:545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rajkowska G, Miguel-Hidalgo JJ. Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 2007; 6:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luby JL, Belden AC, Jackson JJ, et al. Early Childhood Depression and Alterations in the Trajectory of Gray Matter Maturation in Middle Childhood and Early Adolescence. JAMA Psychiatry 2016; 73:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Agtmaal MJM, Houben AJHM, Pouwer F, et al. Association of Microvascular Dysfunction With Late-Life Depression: A Systematic Review and Meta-analysis. JAMA Psychiatry 2017; 74:729.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herrmann LL, Le Masurier M, Ebmeier KP. White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry 2008; 79:619.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller CH, Hamilton JP, Sacchet MD, Gotlib IH. Meta-analysis of Functional Neuroimaging of Major Depressive Disorder in Youth. JAMA Psychiatry 2015; 72:1045.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li W, Chen Z, Wu M, et al. Characterization of brain blood flow and the amplitude of low-frequency fluctuations in major depressive disorder: A multimodal meta-analysis. J Affect Disord 2017; 210:303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russo SJ, Nestler EJ. The brain reward circuitry in mood disorders. Nat Rev Neurosci 2013; 14:609.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pizzagalli DA, Holmes AJ, Dillon DG, et al. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry 2009; 166:702.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morgan JK, Olino TM, McMakin DL, et al. Neural response to reward as a predictor of increases in depressive symptoms in adolescence. Neurobiol Dis 2013; 52:66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hanson JL, Hariri AR, Williamson DE. Blunted Ventral Striatum Development in Adolescence Reflects Emotional Neglect and Predicts Depressive Symptoms. Biol Psychiatry 2015; 78:598.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stringaris A, Vidal-Ribas Belil P, Artiges E, et al. The Brain's Response to Reward Anticipation and Depression in Adolescence: Dimensionality, Specificity, and Longitudinal Predictions in a Community-Based Sample. Am J Psychiatry 2015; 172:1215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldapple K, Segal Z, Garson C, et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 2004; 61:34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lui S, Parkes LM, Huang X, et al. Depressive disorders: focally altered cerebral perfusion measured with arterial spin-labeling MR imaging. Radiology 2009; 251:476.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lustberg L, Reynolds CF. Depression and insomnia: questions of cause and effect. Sleep Med Rev 2000; 4:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thase ME. Depression and sleep: pathophysiology and treatment. Dialogues Clin Neurosci 2006; 8:217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Souêtre E, Salvati E, Belugou JL, et al. Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res 1989; 28:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johansson C, Willeit M, Smedh C, et al. Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology 2003; 28:734.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009; 71:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller AH, Haroon E, Felger JC. Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation. Neuropsychopharmacology 2017; 42:334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strawbridge R, Arnone D, Danese A, et al. Inflammation and clinical response to treatment in depression: A meta-analysis. Eur Neuropsychopharmacol 2015; 25:1532.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67:446.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Dooren FE, Schram MT, Schalkwijk CG, et al. Associations of low grade inflammation and endothelial dysfunction with depression - The Maastricht Study. Brain Behav Immun 2016; 56:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khandaker GM, Pearson RM, Zammit S, et al. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 2014; 71:1121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frank P, Jokela M, Batty GD, et al. Association Between Systemic Inflammation and Individual Symptoms of Depression: A Pooled Analysis of 15 Population-Based Cohort Studies. Am J Psychiatry 2021; 178:1107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raison CL. Inflammatory depression: a trifecta of trouble. J Clin Psychiatry 2014; 75:663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Friedrich MJ. Research on psychiatric disorders targets inflammation. JAMA 2014; 312:474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haroon E, Daguanno AW, Woolwine BJ, et al. Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder. Psychoneuroendocrinology 2018; 95:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65:732.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raison CL, Rutherford RE, Woolwine BJ, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 2013; 70:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kappelmann N, Lewis G, Dantzer R, et al. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol Psychiatry 2018; 23:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Felger JC, Li Z, Haroon E, et al. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry 2016; 21:1358.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verhoeven JE, Révész D, Epel ES, et al. Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study. Mol Psychiatry 2014; 19:895.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Darrow SM, Verhoeven JE, Révész D, et al. The Association Between Psychiatric Disorders and Telomere Length: A Meta-Analysis Involving 14,827 Persons. Psychosom Med 2016; 78:776.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ridout KK, Ridout SJ, Price LH, et al. Depression and telomere length: A meta-analysis. J Affect Disord 2016; 191:237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Révész D, Verhoeven JE, Milaneschi Y, Penninx BW. Depressive and anxiety disorders and short leukocyte telomere length: mediating effects of metabolic stress and lifestyle factors. Psychol Med 2016; 46:2337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verhoeven JE, van Oppen P, Révész D, et al. Depressive and Anxiety Disorders Showing Robust, but Non-Dynamic, 6-Year Longitudinal Association With Short Leukocyte Telomere Length. Am J Psychiatry 2016; 173:617.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wignall ND, Deschner M, Evans HM, Brown ES. Relationship Between Current Depressive Symptoms and Telomere Length in a Large, Multiethnic Sample. J Clin Psychiatry 2017; 78:1331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schutte NS, Malouff JM. The association between depression and leukocyte telomere length: a meta-analysis. Depress Anxiety 2015; 32:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wium-Andersen MK, Ørsted DD, Rode L, et al. Telomere length and depression: prospective cohort study and Mendelian randomisation study in 67 306 individuals. Br J Psychiatry 2017; 210:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nutt DJ, Baldwin DS, Clayton AH, et al. Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment. J Clin Psychiatry 2006; 67 Suppl 6:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Delgado PL, Miller HL, Salomon RM, et al. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry 1999; 46:212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Booij L, van der Does AJ, Haffmans PM, et al. Acute tryptophan depletion as a model of depressive relapse: behavioural specificity and ethical considerations. Br J Psychiatry 2005; 187:148.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ogawa S, Fujii T, Koga N, et al. Plasma L-tryptophan concentration in major depressive disorder: new data and meta-analysis. J Clin Psychiatry 2014; 75:e906.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Delgado PL, Miller HL, Salomon RM, et al. Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacol Bull 1993; 29:389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 2007; 64:327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lener MS, Niciu MJ, Ballard ED, et al. Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine. Biol Psychiatry 2017; 81:886.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanacora G, Mason GF, Rothman DL, et al. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1999; 56:1043.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haroon E, Fleischer CC, Felger JC, et al. Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression. Mol Psychiatry 2016; 21:1351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hasler G, van der Veen JW, Tumonis T, et al. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 2007; 64:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choudary PV, Molnar M, Evans SJ, et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A 2005; 102:15653.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Svenningsson P, Chergui K, Rachleff I, et al. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 2006; 311:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54:597.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thase ME. Molecules that mediate mood. N Engl J Med 2007; 357:2400.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hill MN, Gorzalka BB. Impairments in endocannabinoid signaling and depressive illness. JAMA 2009; 301:1165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heldt SA, Stanek L, Chhatwal JP, Ressler KJ. Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry 2007; 12:656.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Angelucci F, Brenè S, Mathé AA. BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry 2005; 10:345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nasca C, Bigio B, Lee FS, et al. Acetyl-l-carnitine deficiency in patients with major depressive disorder. Proc Natl Acad Sci U S A 2018; 115:8627.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Post RM. Myriad of implications of acetyl-l-carnitine deficits in depression. Proc Natl Acad Sci U S A 2018; 115:8475.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 118669 Version 7.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30027876" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The benefits of antidepressants: news or fake news?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30027876" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : The benefits of antidepressants: news or fake news?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30027876" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : The benefits of antidepressants: news or fake news?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19188629" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Neurobiological mechanisms in major depressive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28618857" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : State-Independent and Dependent Neural Responses to Psychosocial Stress in Current and Remitted Depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19487626" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15953796" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Hypercortisolemia and depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18172175" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Major depressive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11430844" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11015810" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3310667" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8214170" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : The DST as a predictor of outcome in depression: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19693001" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Neurocircuitry of mood disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25133665" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Abnormal amygdala resting-state functional connectivity in adolescent depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18400922" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The brain's default network: anatomy, function, and relevance to disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25785575" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Large-Scale Network Dysfunction in Major Depressive Disorder: A Meta-analysis of Resting-State Functional Connectivity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23842648" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Neuronal network plasticity and recovery from depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29562053" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Neural Markers of Resilience in Adolescent Females at Familial Risk for Major Depressive Disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27918562" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Resting-state connectivity biomarkers define neurophysiological subtypes of depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28335622" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27755933" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Psychoradiology: The Frontier of Neuroimaging in Psychiatry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25390502" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Anterior insula volume and guilt: neurobehavioral markers of recurrence after early childhood major depressive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26122586" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27137745" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27749245" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Accelerated aging of the putamen in patients with major depressive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25651064" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Identification of a common neurobiological substrate for mental illness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12900317" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Untreated depression and hippocampal volume loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14594756" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Association of depression duration with reduction of global cerebral gray matter volume in female patients with recurrent major depressive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17335636" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19441021" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25065859" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Brain grey matter abnormalities in medication-free patients with major depressive disorder: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20015483" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Hippocampal changes associated with early-life adversity and vulnerability to depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20194827" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Decreased hippocampal volume in healthy girls at risk of depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24126515" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22394416" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Brain-volume increase with sustained remission in patients with treatment-resistant unipolar depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29590274" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : A Promising Future Role for Neuroimaging in Tracking and Predicting Relapse in Major Depressive Disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29590315" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Association of Brain Cortical Changes With Relapse in Patients With Major Depressive Disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28499208" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Whole-brain resting-state functional connectivity identified major depressive disorder: A multivariate pattern analysis in two independent samples.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25891219" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Voxel-Based Meta-Analytical Evidence of Structural Disconnectivity in Major Depression and Bipolar Disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27780031" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Microstructural brain abnormalities in medication-free patients with major depressive disorder: a systematic review and meta-analysis of diffusion tensor imaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28717197" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Subcortical volume and white matter integrity abnormalities in major depressive disorder: findings from UK Biobank imaging data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25062597" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : White matter correlates of adolescent depression: structural evidence for frontolimbic disconnectivity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24330845" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Altered white-matter architecture in treatment-naive adolescents with clinical depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29672517" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : White matter alterations in the internal capsule and psychomotor impairment in melancholic depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20004363" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17063153" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11884354" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11386983" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17511618" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Gliogenesis and glial pathology in depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26676835" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Early Childhood Depression and Alterations in the Trajectory of Gray Matter Maturation in Middle Childhood and Early Adolescence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28564681" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Association of Microvascular Dysfunction With Late-Life Depression: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17717021" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : White matter hyperintensities in late life depression: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26332700" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Meta-analysis of Functional Neuroimaging of Major Depressive Disorder in Youth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28068619" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Characterization of brain blood flow and the amplitude of low-frequency fluctuations in major depressive disorder: A multimodal meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23942470" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The brain reward circuitry in mood disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19411368" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22521464" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Neural response to reward as a predictor of increases in depressive symptoms in adolescence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26092778" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Blunted Ventral Striatum Development in Adolescence Reflects Emotional Neglect and Predicts Depressive Symptoms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26085042" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : The Brain's Response to Reward Anticipation and Depression in Adolescence: Dimensionality, Specificity, and Longitudinal Predictions in a Community-Based Sample.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14706942" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19401575" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Depressive disorders: focally altered cerebral perfusion measured with arterial spin-labeling MR imaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12531168" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Depression and insomnia: questions of cause and effect.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16889107" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Depression and sleep: pathophysiology and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2762432" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12655319" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19188531" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27555382" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26169573" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Inflammation and clinical response to treatment in depression: A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20015486" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : A meta-analysis of cytokines in major depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26970354" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Associations of low grade inflammation and endothelial dysfunction with depression - The Maastricht Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25133871" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34645276" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Association Between Systemic Inflammation and Individual Symptoms of Depression: A Pooled Analysis of 15 Population-Based Cohort Studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25004190" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Inflammatory depression: a trifecta of trouble.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25054339" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Research on psychiatric disorders targets inflammation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29800779" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19150053" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22945416" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27752078" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26552591" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24217256" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27359174" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : The Association Between Psychiatric Disorders and Telomere Length: A Meta-Analysis Involving 14,827 Persons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26688493" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Depression and telomere length: A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27266474" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Depressive and anxiety disorders and short leukocyte telomere length: mediating effects of metabolic stress and lifestyle factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26940806" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Depressive and Anxiety Disorders Showing Robust, but Non-Dynamic, 6-Year Longitudinal Association With Short Leukocyte Telomere Length.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28297596" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Relationship Between Current Depressive Symptoms and Telomere Length in a Large, Multiethnic Sample.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25709105" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : The association between depression and leukocyte telomere length: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27810892" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Telomere length and depression: prospective cohort study and Mendelian randomisation study in 67 306 individuals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16848678" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10418696" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16055826" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Acute tryptophan depletion as a model of depressive relapse: behavioural specificity and ethical considerations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25295433" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Plasma L-tryptophan concentration in major depressive disorder: new data and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8121966" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17339521" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : The role of dopamine in the pathophysiology of depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27449797" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10565505" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26754953" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17283286" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16230605" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16400147" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Alterations in 5-HT1B receptor function by p11 in depression-like states.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9236543" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : A molecular and cellular theory of depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18057345" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Molecules that mediate mood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19293417" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Impairments in endocannabinoid signaling and depressive illness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17264839" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15655562" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : BDNF in schizophrenia, depression and corresponding animal models.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30061399" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Acetyl-l-carnitine deficiency in patients with major depressive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30068605" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Myriad of implications of acetyl-l-carnitine deficits in depression.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
